ADMD Financials 07/16/2014 11:53:11
Advanced Medical Isotope Corp.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 141 248 394 361
Cost of Revenue 105 73 64 70
Gross Profit 35 175 330 290
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 3,406 5,563 2,345 3,321
Non-Recurring Items - - - 150
Other 209 483 546 545
Operating Income (3,580) (5,871) (2,562) (3,725)
Income From Continuing Operations
Add'l Income/Expense Items 1,710 (1,613) 221 531
Earnings Before Interest and Tax (1,870) (7,484) (2,341) (3,195)
Interest Expense 1,601 1,102 408 860
Earnings Before Tax (3,471) (8,586) (2,750) (4,055)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (3,569) (8,635) (2,750) (4,028)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (3,471) (8,586) (2,750) (4,055)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (3,471) (8,586) (2,750) (4,055)